Abstract
Peritoneal metastases of colorectal cancer are a complex entity with poor prognosis but some patients may benefit from a multidisciplinary approach that includes radical surgical resection using cytoreductive surgery (CRS). This approach remains controversial due to incomplete consensus regarding patient selection criteria, perceived high postoperative morbidity and lack of consistent survival data from current large prospective cohorts. The optimal care delivery model for patients with peritoneal metastases who may be candidates for aggressive treatments has not been defined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
